These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The current status of mycophenolate mofetil in pediatric renal transplantation. Tönshoff B. Pediatr Transplant; 1999 Feb; 3(1):5-9. PubMed ID: 10359025 [No Abstract] [Full Text] [Related]
12. Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation. Baker GM, Martin JE, Jang R, Schroeder TJ, Armitstead JA, Myre S, First MR. Transplant Proc; 1998 Dec; 30(8):4082-4. PubMed ID: 9865304 [No Abstract] [Full Text] [Related]
13. [Pharmacological profiles of mycophenolate mofetil (CellCept), a new immunosuppressive agent]. Yashima Y, Ohgane T. Nihon Yakurigaku Zasshi; 2001 Feb; 117(2):131-7. PubMed ID: 11233304 [Abstract] [Full Text] [Related]
14. Mycophenolate mofetil versus azathioprine in organ transplantation. Cravedi P, Perna A, Ruggenenti P, Remuzzi G. Am J Transplant; 2009 Dec; 9(12):2856-7. PubMed ID: 19845579 [No Abstract] [Full Text] [Related]
15. RS-61443: a new immunosuppressive agent. Young CJ, Sollinger HW. Transplant Proc; 1994 Dec; 26(6):3144-6. PubMed ID: 7998096 [No Abstract] [Full Text] [Related]
16. Enteric-coated mycophenolate sodium: an update. Zhang W, Ding C, Zheng S. Int J Clin Pract Suppl; 2014 Apr; (181):1-3. PubMed ID: 24673712 [No Abstract] [Full Text] [Related]
17. Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection. Klupp J, van Gelder T, Dambrin C, Regieli JJ, Boeke K, Billingham ME, Morris RE. J Heart Lung Transplant; 2004 Mar; 23(3):334-51. PubMed ID: 15019644 [Abstract] [Full Text] [Related]
18. Mycophenolate mofetil (CellCept): immunosuppression on the cutting edge. Siconolfi L. AACN Clin Issues; 1996 Aug; 7(3):390-402. PubMed ID: 8826401 [Abstract] [Full Text] [Related]
19. Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation. Lederer SR, Friedrich N, Banas B, Welser G, Albert ED, Sitter T. Clin Transplant; 2005 Apr; 19(2):168-74. PubMed ID: 15740551 [Abstract] [Full Text] [Related]
20. Inhibition of inosine monophosphate dehydrogenase activity by the plasma of heart transplant recipients receiving mycophenolate mofetil. Griesmacher A, Weigel G, Seebacher G, Mallinger R, Laufer G, Müller MM. Adv Exp Med Biol; 1998 Apr; 431():537-41. PubMed ID: 9598124 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]